Interesting point. I can foresee the same type of scenario taking place with Squalamine for AMD. Patients in a Phase II/III study "jumping ship" to eliminate further vision loss.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.